MVM has been investing in healthcare businesses since 1997. These include medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, and digital health. They have teams in Boston and London.
MVM Life Science Partners has made 52 investments. Their most recent investment was on September 20, 2018, when Providence Medical Technology raised $25 million. Other investments include Zipline Medical, VitalConnect, Cheetah Medical, Vertos Medical and Valneva.
MVM Life Science Partners has had 18 exits. MVM Life Science Partners's most notable exits include Cheetah Medical, Horizon Discovery, and Heptares Therapeutics.
Funding Rounds Participated In
- Venture capitalVenture capital is a form of private equity financing that is provided by venture capital firms or funds to startups, early-stage , and emerging companies, that have been deemed to have high growth potential or which have demonstrated high growth. Capital invested usually carries a substantial element of risk.